
Textured breast implants sold by a major pharmaceutical firm exposed Australian women to a higher risk of cancer and should never have been sold to the public, a lawsuit claims.
Allergan, one of the manufacturers of these now-banned implants, could be facing a hefty damages bill after a class action lawsuit was filed in the Federal Court in November.